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poglycemic therapy is crucial for good glycemic control, this study aimed to com-
pare medication adherence to oral hypoglycemic therapy, as well as diabetic care
and risk of acute complications between type II diabetics with schizophrenia ver-
sus those without schizophrenia.METHODS: This study used the National Health
Insurance claims data of a randomly selected sample. Enrollees who had received
oral hypoglycemic therapy in 2002 and had been diagnosed with schizophrenia
were included in the study (the case group). Enrollees without schizophrenia who
had received oral hypoglycemic therapy in 2002were selected tomatch the age and
gender of the case group (1:3) (the comparison group). All subjects were observed
for one year after their index dates – the dates of their first filled prescriptions in
2002. Medication possession ratio (MPR) was measured as MPR0.8 indicated poor
adherence. Indicators of diabetic care included blood glucose test and HbA1c test.
Acute complicationswere defined as emergency roomvisits or hospital admissions
due to coma, hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Logisticmod-
els were used to evaluate likelihood of poor medication adherence and access to
diabetic care. Cox proportional hazards model was adopted to assess risk of acute
complications. RESULTS: There were 202 and 606 subjects in the case group and
comparison group, respectively. The mean age was 52, and 48% were male. Ap-
proximately half of both groups were poorly adherent to their oral hypoglycemic
therapy. Diabetics with schizophrenia were less likely to receive HbA1c test. Their
risks of acute complications were comparable. CONCLUSIONS: According to our
preliminary results, diabetics with schizophrenia, compared with those without
such a condition, had worse diabetic care. Better disease management will be
necessary for this patient group.
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OBJECTIVES:The impact of dementia andAlzheimer’s disease (AD) are devastating
onmany levels, including the effects on the families/caregivers of the patient. This
study was designed to describe and evaluate the characteristics of a cohort of
Chinese dementia patients, including associated caregivers’ burden.METHODS: A
3-month open-enrollment, multi-center study was conducted at 48 tier 3 hospitals
across mainland China in 2009. Caregivers who accompanied dementia patients
were asked to participate in the caregiver assessment survey. Interviews included
information on caregiver profile, patient care, and caregivers’ burden. Caregiver
burden was measured using the Chinese version of the validated Zarit Burden
Interview (ZBI). Disease severity was measured by the Clinical Dementia Rating
(CDR). RESULTS: A total of 1425 dementia patients with 1387 associated caregivers
completed the Chinese version of the ZBI. Dementia patients from this cohort were
considered to have mild to moderate dementia (mean CDR score 1.67 [SD0.79]).
ADwas themost commondementia subtype among this cohort (46.7%) followed by
vascular dementia (28.7%). Among the caregivers who participated in this survey:
57% were female, 51% identified as the spouse of the dementia patient, and 67.3%
had been caring for the dementia subject more than one year. Dementia caregiver
burden was mild to moderate (mean total ZBI score of 26.6), regardless of age,
gender, level of education, type of dementia, CDR, and duration of care. The care-
giver burden increases over time and is associated with the progression of the
disease. CONCLUSIONS: Dementia has significant emotional and social impact
(measured by ZBI) on patients and caregivers, regardless of demographics and
geography. In China, these challenges may be mitigated by improving public edu-
cation and increasing public awareness on the signs and symptoms of dementia vs
normal aging.
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RESILIENCE RESOURCES PREDICT HIGHER QUALITY OF LIFE (QOL) AMONG
TAIWANESE DIALYSIS PATIENTS
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OBJECTIVES: This study with in-centre haemodialysis patients examined the im-
pact of personal psychological resilience resources, social support, hopefulness,
and perceived loss of control to doctor on mental health outcomes. We hypothe-
sized that resilience resources are the overarching principle determining QOL
among these predictors. METHODS: Non-invasive study with cross-sectional de-
sign, using quantitative data collected from standardized self-report measures
(N294). Predictor variables included: resilience resources (perceived control, op-
timism, self-esteem); social support; loss of control to doctor; hope. Control vari-
ables included: gender; age; relationship, vocational, socio-economic status; living
alone; cultural identity; religious beliefs; and disease-related variables such as
cause of renal failure, number of co-morbidities, time since dialysis onset, trans-
plant status, kidney disease impact. Outcome measure: Mental Composite Score
(MCS) of SF-36v2® health survey. RESULTS: Only questionnaires without missing
data were included in the analysis (n219). Significant relationships (p0.01) were
observed of MCS with employment status (r0.25); socioeconomic status (r.30);
kidney disease impact (r0.60); social support (r0.21); hope (r0.27); loss of con-
trol to doctor (r0.16); self-esteem (r.51); optimism (r0.40); perceived control
(r.40). Hierarchical multiple regressionmodel explained 48 percent of variance in
MCS, F(9,209)23.04, p.01. Demographic variables (block 1, 
R2.12,
F(2,216)15.24, p0.01), disease impact (block 2, 
R2.29, F(1,215)104.15, p0.01),
and resilience resources (block 4, 
R2.08, F(3,209)11.48, p0.01) explained a sig-
nificant portion of variance inMCS. Social support, hopefulness, and perceived loss
of control to doctor (block 3, 
R20.01, F(3,212)0.70) were not able to explain a
significant portion of variance in MCS. CONCLUSIONS: Resilience resources ac-
counted for 8 percent of variance over and above all other predictors. Confirming
the hypothesis, variables such as social support that had predicted mental health
in earlier studies became insignificant. Future research should identify less resil-
ient patients andmake positive psychology approaches available to see if outcome
can be improved in clinical practice.
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OBJECTIVES: To investigate the irrational prescription habit of steroids by medical
practitioners in patients with arthritis and lower back pain in the area.METHODS:
Twenty-nine pharmacies were randomly selected in various areas of the Province
and 321 prescriptions of those patients with complaints of arthritis or lower back
pain were evaluated for use of steroids (corticosteroids). RESULTS: A total of 103
out of 321 prescriptions (about 30 %) were containing corticosteroids and the pa-
tients were using these steroids mostly in an irrational manner. These prescrip-
tions were prescribed by medical practitioners of all specialties including orthope-
dics. A small number of non medical doctors (about 2%) were also responsible for
the steroids prescriptions. CONCLUSIONS: This study indicates that this type of
irrational practice is the reflection of state and regulatory affairs in the country and
this is a warning for all developing countries which need strict regulations for
steroid prescriptions.
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OBJECTIVES: Using a national database to evaluate the risk of ONJ in osteoporosis
females in Taiwan. METHODS: We used the population-based National Health
Insurance (NHI) database in Taiwan to conduct a retrospective cohort study during
the period from 2000 through 2008. The study population confined to the women
who took alendronate or raloxifene initially from Jan, 2001 to Sep, 2005 and medi-
cation needed to be stably prescribed for 90 days. The measurements of clinical
outcomes includedONJ-diagnosis (ICD-9-CMdiagnosis code 526.4, 526.5, 528.3, and
730.18) and sequestrectomy (NHI payment code: 92025B and 92026B) within 3 years
after stable medication use. Cox’s proportional hazard model was used to analyze
the risk of ONJ development. RESULTS:We identified 23,158 womenwho had been
prescribed either alendronate (n  18,504) or raloxifene (n  4,654). The patients
treated with alendronate were at a higher risk of ONJ-diagnosis compared with the
raloxifene group (hazard ratio [HR]  1.336 [95% CI, 1.100-1.622]). For sequestrec-
tomy, patients took alendronate also had a higher risk than raloxifene group
(HR4.648 [95% CI, 1.120-19.291]). CONCLUSIONS: Patients who took alendronate
had a higher risk of ONJ than raloxifene patients, nomatter from the perspective of
having the diagnosis or performing sequestrectomy. When undertaking the bis-
phophonates treatment, doctors need to pay attention to the oral condition of
patients.
PMS4
INHIBITION OF CARRAGEENAN-INDUCED EDEMA BY STACHYS FRUTICULOSA
EXTRACT IN RATS
Bakhtiarian A1, Araghi S2, Khanavi M1
1Tehran University of Medical Sciences, Tehran, Iran, 2Tehran University of Medical Sciences,
Tehran, Iran
OBJECTIVES: In this research, anti-inflammatory effect of Stachys Fruticulosa-
M.Bieb. extract was studied in rats. METHODS: The effect of the extract against
acute inflammation was studied by hind paw edema test. Intraperitoneal injection
of different doses (50, 100, 200 and 300 mg/kg) of Stachys Fruticulosa which was
followed by hind paw carageenan injection 1 h later were investigated. The resul-
tant edema was quantified by measuring the hind paw edema with three ways of
measurement: micrometer method, paw circumference (PC), plethysmometer
method. RESULTS: After 2, 4 and 6 h we measured the anti-inflammatory effect of
Stachys Fruticulosa extract. Stachys Fruticulosa extract with doses of 100, 200 and
300 mg/kg and indomethacin at a dose of 5 mg/kg showed significant effect.
CONCLUSIONS: It is concluded that themethanolic extract of Stachys fruticulosa -
M.Bieb. has anti-inflammatory effect which can be used as an alternative for Indo-
methacin for treatment of inflammation. Also it might be advantageous to use this
herbal drug as a synergist for Indomethacin anti-inflammatory effects, to lower the
dosage and consequently.
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A RANDOMIZED, PLACEBO CONTROLLED TRIAL TO COMPARE SAFETY AND
EFFICACY BETWEEN CURCUMA LONGA LINN EXTRACT [NR-INF-02],
GLUCOSAMINE SULPHATE AND COMBINATION OF TWO IN THE TREATMENT
OF PAINFUL KNEE OSTEOARTHRITIS
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OBJECTIVES: Osteoarthritis [OA] a common, chronic disabling condition in ortho-
paedic practice is routinely treated with non-steroidal anti-inflammatory drugs
[NSAIDs] which are often associated with serious adverse reactions while long
term Glucosamine sulphate [GS] is frequently used to halt its progression. Objec-
tive of this studywas to compare safety and efficacy of herbal formulationNRINF02
and Glucosamine sulphate alone and their combination with placebo in treatment
of patientswithOA.METHODS:A randomized, single blind, placebo controlled trial
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